Previous Close | 182.74 |
1-Year Change | 50.85% |
6-Months Change | 6.66% |
3-Months Change | 6.73% |
Moving Avg (50d) | 195.76 |
Moving Avg (200d) | 161.16 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 5.15B |
Beta (3-Years) | 1.49 |
Revenue Growth (ttm) | % |
Net Profit Margin (ttm) | -348.43% |
Return On Assets (ttm) | -3.77% |
EPS (ttm) | -1.47 |
PE Ratio (ttm) | -124.31 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |